The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chemkart India, listed on BSE SME in July 2025, reported consolidated revenue of Rs. 10,322.56 lakhs for H1 FY26, up 14.5% sequentially from H2 FY25 (Rs. 9,015.24 lakhs) but down from Rs. 11,312.61 lakhs in H1 FY25. Profit after tax rose to Rs. 1,015.26 lakhs (from Rs. 889.57 lakhs), with annualised EPS of Rs. 9.50. The balance sheet strengthened sharply post-IPO, with cash jumping to Rs. 4,374.58 lakhs and net worth to Rs. 12,022.41 lakhs. Short-term borrowings fell dramatically from Rs. 1,692.62 lakhs to Rs. 126.44 lakhs. IPO proceeds of Rs. 6,448 lakhs are being deployed toward a new manufacturing facility at JNPA SEZ (Rs. 3,468 lakhs), debt repayment, and general corporate purposes.
Strong post-IPO liquidity and debt-light balance sheet are positive for shareholders, but the YoY revenue and margin contraction versus H1 FY25 is a watch point. Manufacturing facility remains on track for FY 2026-27 commissioning.